Transcenta Holding Limited (HKG:6628)
Hong Kong
· Delayed Price · Currency is HKD 1.460
+0.030 (2.10%)
Jun 27, 2025, 4:08 PM HKT
Transcenta Holding Revenue
In the year 2024, Transcenta Holding had annual revenue of 11.26M CNY, down -79.09%. Transcenta Holding had revenue of 6.70M in the half year ending December 31, 2024, a decrease of -91.64%.
Revenue
11.26M CNY
Revenue Growth
-79.09%
P/S Ratio
49.44
Revenue / Employee
61.20K CNY
Employees
184
Market Cap
592.52M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 28.99B |
| Akeso | 2.26B |